SL-11047 in Treating Patients With Relapsed or Refractory Lymphoma
This study has been completed.
Sponsor:
Progen Pharmaceuticals
Collaborator:
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00293488
First received: February 16, 2006
Last updated: September 22, 2008
Last verified: September 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Primary Completion Date: | September 2008 (Final data collection date for primary outcome measure) |